Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Efficacy of VERIGENE® Blood Culture Assays in Accurately and Rapidly Detecting Gram-Negative and Gram-Positive Pathogens

Author(s): Roberto Guevara, Monique G. Davis, Michelle A. Davis, Sara Ahmed, Sidra Shah, Karla Cuaron and Suresh J. Antony*

Volume 22, Issue 5, 2022

Published on: 07 March, 2022

Article ID: e100122200121 Pages: 6

DOI: 10.2174/1871526522666220110155719

Price: $65

Abstract

Background: Rapid administration of appropriately indicated antibiotics is crucial in septic patients. Sepsis data supports that there is a higher risk of mortality for each hour delay from triage to antibiotic therapy, as well as for inappropriate antibiotic selection. There are a variety of rapid microbial detection systems, such as VERIGENE®, used in acute care facilities to rapidly detect bacteremia and identify resistance markers. Our study investigates the usefulness of VERIGENE® assays in accurately detecting Gram-positive and Gram-negative pathogens when compared to traditional blood culture analysis systems, such as VITEK®.

Methods: 819 Gram-positive and 373 Gram-negative blood samples were collected and tested using both VERIGENE® and VITEK®. Statistical tests were two-tailed and observations were defined as statistically significant if P ≤ 0.05.

Results: VERIGENE® detected a pathogen in 816/819 (99.6%) samples of the Gram-positive blood cultures and 367/373 (98.3%) samples of the Gram-negatives compared to 805/819 (98.3%) and 367/373 (98.4%), respectively, using VITEK®. Gram-positive cultures had a sensitivity of 99.5% and a specificity of 27.3% (PPV 99.0%, NPV 42.9%, 98.7% accuracy) with VERIGENE analysis. Gramnegatives had a sensitivity of 99.2% and a specificity of 20.0% (PPV 98.9%, NPV 25.0%, 98.4% accuracy).

Conclusion: Although statistically insignificant (P = 0.25), VERIGENE® was 1.3% more likely to identify Gram-positive bacteria when compared to conventional methods. Overall, we concluded that VERIGENE® assays are valuable in their ability to rapidly detect microorganisms and resistance markers, given their high sensitivities. This allows for select targeted therapy in patients with sepsis and can ultimately reduce mortality rates.

Keywords: VERIGENE®, microarray assays, blood cultures, sepsis, antibiotic resistance, Gram-negative and Gram-positive pathogens.

Graphical Abstract

[1]
Prescott HC, Angus DC. Enhancing recovery from sepsis: A review. JAMA 2018; 319(1): 62-75.
[http://dx.doi.org/10.1001/jama.2017.17687] [PMID: 29297082]
[2]
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311(13): 1308-16.
[http://dx.doi.org/10.1001/jama.2014.2637] [PMID: 24638143]
[3]
Thaden JT, Fowler VG, Sexton DJ, Anderson DJ. Increasing incidence of extended-spectrum ;-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States. Infect Control Hosp Epidemiol 2016; 37(1): 49-54.
[http://dx.doi.org/10.1017/ice.2015.239] [PMID: 26458226]
[4]
Castanheira M, Farrell SE, Krause KM, Jones RN, Sader HS. Contemporary diversity of ;-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent ;-lactamase groups. Antimicrob Agents Chemother 2014; 58(2): 833-8.
[http://dx.doi.org/10.1128/AAC.01896-13] [PMID: 24247134]
[5]
Scheer CS, Fuchs C, Gründling M, et al. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: A prospective clinical cohort study. Clin Microbiol Infect 2019; 25(3): 326-31.
[http://dx.doi.org/10.1016/j.cmi.2018.05.016] [PMID: 29879482]
[6]
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43(3): 304-77.
[http://dx.doi.org/10.1007/s00134-017-4683-6] [PMID: 28101605]
[7]
Kim RY, Ng AM, Persaud AK, et al. Antibiotic timing and outcomes in sepsis. Am J Med Sci 2018; 355(6): 524-9.
[http://dx.doi.org/10.1016/j.amjms.2018.02.007] [PMID: 29891035]
[8]
Seymour CW, Kahn JM, Martin-Gill C, et al. Delays from first medical contact to antibiotic administration for sepsis. Crit Care Med 2017; 45(5): 759-65.
[http://dx.doi.org/10.1097/CCM.0000000000002264] [PMID: 28234754]
[9]
Allison MG, Heil EL, Hayes BD. Appropriate antibiotic therapy. Emerg Med Clin North Am 2017; 35(1): 25-42.
[http://dx.doi.org/10.1016/j.emc.2016.08.003] [PMID: 27908336]
[10]
Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis 2021; 21(2): 241-51.
[http://dx.doi.org/10.1016/S1473-3099(20)30477-1] [PMID: 32916100]
[11]
Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science 2016; 352(6285): 544-5.
[http://dx.doi.org/10.1126/science.aad9358] [PMID: 27126037]
[12]
Yoon MY, Yoon SS. Disruption of the gut ecosystem by antibiotics. Yonsei Med J 2018; 59(1): 4-12.
[http://dx.doi.org/10.3349/ymj.2018.59.1.4] [PMID: 29214770]
[13]
Sommer MO, Dantas G. Antibiotics and the resistant microbiome. Curr Opin Microbiol 2011; 14(5): 556-63.
[http://dx.doi.org/10.1016/j.mib.2011.07.005] [PMID: 21802347]
[14]
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol 2015; 21(29): 8787-803.
[http://dx.doi.org/10.3748/wjg.v21.i29.8787] [PMID: 26269668]
[15]
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med 2016; 8(1): 51.
[http://dx.doi.org/10.1186/s13073-016-0307-y]
[16]
The Verigene System. Luminex Corporation https://www.luminexcorp.com/the-verigene-system/#overview
[17]
De Angelis G, Grossi A, Menchinelli G, Boccia S, Sanguinetti M, Posteraro B. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: A systematic review and meta-analysis. Clin Microbiol Infect 2020; 26(3): 271-80.
[http://dx.doi.org/10.1016/j.cmi.2019.11.009] [PMID: 31751768]
[18]
Huang HS, Tsai CL, Chang J, Hsu TC, Lin S, Lee CC. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: Systematic review and meta-analysis. Clin Microbiol Infect 2018; 24(10): 1055-63.
[http://dx.doi.org/10.1016/j.cmi.2017.11.018] [PMID: 29208560]
[19]
Kim JS, Kang GE, Kim HS, Kim HS, Song W, Lee KM. Evaluation of verigene blood culture test systems for rapid identification of positive blood cultures. BioMed Res Int 2016; 2016: 1081536.
[http://dx.doi.org/10.1155/2016/1081536] [PMID: 26904669]
[20]
Scott LJ. Verigene® gram-positive blood culture nucleic acid test. Mol Diagn Ther 2013; 17(2): 117-22.
[http://dx.doi.org/10.1007/s40291-013-0021-z] [PMID: 23345071]
[21]
Cornaglia G, Akova M, Amicosante G, et al. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: Open issues. Int J Antimicrob Agents 2007; 29(4): 380-8.
[http://dx.doi.org/10.1016/j.ijantimicag.2006.10.008] [PMID: 17223319]
[22]
Siu GK, Chen JH, Ng TK, et al. Performance evaluation of the verigene gram-positive and gram-negative blood culture test for direct identification of bacteria and their resistance determinants from positive blood cultures in Hong Kong. PLoS One 2015; 10(10): e0139728.
[http://dx.doi.org/10.1371/journal.pone.0139728]
[23]
Kikuchi K, Matsuda M, Iguchi S, et al. Potential impact of rapid blood culture testing for gram-positive bacteremia in Japan with the verigene gram-positive blood culture test. Can J Infect Dis Med Microbiol 2017; 2017: 4896791.
[http://dx.doi.org/10.1155/2017/4896791] [PMID: 28316631]
[24]
Walker T, Dumadag S, Lee CJ, et al. Clinical impact of laboratory implementation of verigene BC-GN microarray-based assay for detection of gram-negative bacteria in positive blood cultures. J Clin Microbiol 2016; 54(7): 1789-96.
[http://dx.doi.org/10.1128/JCM.00376-16] [PMID: 27098961]
[25]
Altun O, Almuhayawi M, Ullberg M, Ozenci V. Clinical evaluation of the filmarray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 2013; 51(12): 4130-6.
[http://dx.doi.org/10.1128/JCM.01835-13] [PMID: 24088863]
[26]
Ledeboer NA, Lopansri BK, Dhiman N, et al. Identification of gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the verigene gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol 2015; 53(8): 2460-72.
[http://dx.doi.org/10.1128/JCM.00581-15] [PMID: 25994165]
[27]
La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009; 4(11): e8041.
[http://dx.doi.org/10.1371/journal.pone.0008041]

Rights & Permissions Print Cite
Article Metrics
30
1
© 2024 Bentham Science Publishers | Privacy Policy